Mostrando ítems 1-1 de 1
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial
Labarga, Pablo; Barreiro, Pablo; Silva, Alfredo da; Guardiola, Josep María; Rubio, Rafael; Aguirrebengoa, Koldo; Miralles, Pilar; Portu, Joseba; Téllez, María Jesús; Morano, Luis; Castro-Iglesias, Ángeles; Pineda, Juan Antonio; Terrón, Alberto; Hernández-Quero, José; Mariño, Ana; Ríos, María José; Echeverría, Santiago; Asensi, Víctor; Vispo, Eugenia; Soriano, Vincent (Oxford, 2012-07-17)[Abstract] BACKGROUND: Ribavirin (RBV) exposure seems to be critical to maximize treatment response in human immunodeficiency virus (HIV)-positive patients with chronic hepatitis C virus (HCV) infection. METHODS: ...
